Modicus Prime provides a Trustworthy AI Compliance Software platform that integrates with pharmaceutical tech stacks and quality management systems to create a single source of truth for AI compliance across the full lifecycle. The platform is designed to make AI applications in GxP environments audit-ready for pharmaceutical companies, CROs, CMOs, CDMOs and adjacent regulated sectors, and to translate between data science, IT, quality and compliance functions. Modicus Prime says its platform supports biologics, cell and gene therapies, and vaccine manufacturing across global regulatory environments including FDA and EMA requirements. Leadership has contributed to industry guidance—CEO Taylor Chartier co-authored the ISPE GAMP AI Guide and BioPhorum AI Implementation publication and led ISPE's GxP AI Webinar Series—positioning the company as an active participant in regulatory and educational initiatives. The company is using recent funding to expand customer support and continue platform enhancements to better support deployments and growing AI compliance needs. Modicus Prime was formerly a resident at Johnson & Johnson Innovation – JLABS @ Texas Medical Center and is currently associated with JLABS @ South San Francisco.

Total raised

$8M

Funding rounds

2

Latest round

Equity

Latest activity

May 2026